Literature DB >> 19492172

Evaluation of orofacial motricity in patients with mucopolysaccharidosis: a cross-sectional study.

Giovana S Turra1, Ida Vanessa D Schwartz.   

Abstract

OBJECTIVES: To characterize the stomatognathic system and stomatognathic functions in patients with mucopolysaccharidosis.
METHODS: Cross-sectional and observational study of patients with mucopolysaccharidosis seen at the outpatient clinic at the Medical Genetics Service of Hospital de Clínicas de Porto Alegre. The inclusion criteria were the existence of a biochemical or molecular diagnosis of any type of mucopolysaccharidosis and the agreement to participate in the study by signing an informed consent form. Seventy-eight patients were evaluated through phonoaudiological anamnesis and physical exam.
RESULTS: Alterations in at least one item of each structure of the stomatognathic system or stomatognathic function were found in all patients who allowed evaluation of both items on physical examination (n = 76/78). The most frequently compromised structures and functions were respectively the dental arch and the tongue, swallowing and mastication. The only statistically significant difference found between types of mucopolysaccharidosis involved the habitual position of the tongue between the teeth (most frequent in mucopolysaccharidosis VI). Among patients with mucopolysaccharidosis I, II or VI who underwent enzyme replacement therapy or not, there was statistically significant difference in oral breathing mode (more frequent in the group without enzyme replacement therapy).
CONCLUSIONS: Alterations in stomatognathic systems and functions are prevalent among individuals with mucopolysaccharidosis, even if enzyme replacement therapy is administered. Such finding suggests that speech therapy follow-up plays a major role in the treatment plan of this group of diseases; this hypothesis should be confirmed by additional studies.

Entities:  

Mesh:

Year:  2009        PMID: 19492172     DOI: 10.2223/JPED.1899

Source DB:  PubMed          Journal:  J Pediatr (Rio J)        ISSN: 0021-7557            Impact factor:   2.197


  4 in total

1.  Evaluation of oral manifestations of patients with mucopolysaccharidosis IV and VI: clinical and imaging study.

Authors:  Renata Quirino de Almeida-Barros; Paula Frassinetti Vasconcelos de Medeiros; Marcella Quirino de Almeida Azevedo; Adriana de Oliveira Lira Ortega; Angela Toshie Araki Yamamoto; Sheyla Kátia Lúcio Dornelas; Patrícia Meira Bento
Journal:  Clin Oral Investig       Date:  2017-03-19       Impact factor: 3.573

2.  Enzyme replacement therapy for Mucopolysaccharidosis Type I among patients followed within the MPS Brazil Network.

Authors:  Alícia Dorneles Dornelles; Louise Lapagesse de Camargo Pinto; Ana Carolina de Paula; Carlos Eduardo Steiner; Charles Marques Lourenço; Chong Ae Kim; Dafne Dain Gandelman Horovitz; Erlane Marques Ribeiro; Eugênia Ribeiro Valadares; Isabela Goulart; Isabel C Neves de Souza; João Ivanildo da Costa Neri; Luiz Carlos Santana-da-Silva; Luiz Roberto Silva; Márcia Ribeiro; Ruy Pires de Oliveira Sobrinho; Roberto Giugliani; Ida Vanessa Doederlein Schwartz
Journal:  Genet Mol Biol       Date:  2013-02-28       Impact factor: 1.771

3.  Oral Health Status of Patients with Lysosomal Storage Diseases in Poland.

Authors:  Damian Drążewski; Małgorzata Grzymisławska; Katarzyna Korybalska; Natasza Czepulis; Marian Grzymisławski; Janusz Witowski; Anna Surdacka
Journal:  Int J Environ Res Public Health       Date:  2017-03-09       Impact factor: 3.390

4.  Dental and maxillomandibular incidental findings in panoramic radiography among individuals with mucopolysaccharidosis: a cross-sectional study.

Authors:  Natália Cristina Ruy Carneiro; Lucas Guimarães Abreu; Roselaine Moreira Coelho Milagres; Tania Mara Pimenta Amaral; Carlos Flores-Mir; Isabela Almeida Pordeus; Ana Cristina Borges-Oliveira
Journal:  J Appl Oral Sci       Date:  2021-04-14       Impact factor: 2.698

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.